COVID-19 infection may have lasting or delayed effects on heart
The number of people coronavirus disease 2019 (COVID-19) is rising with more cases in the U.S. (5M according to the Centers for Disease Control and
Heart Attack
Heart attack is a medical condition of sudden interruption or insufficiency of the supply of blood to the heart, typically resulting from occlusion or obstruction of a coronary artery and often characterized by severe chest pain. Also called myocardial infarction.
Evenity approved to treat osteoporosis in postmenopausal women
The U.S. Food and Drug Administration approved Evenity (romosozumab-aqqg) to treat osteoporosis in postmenopausal women at high risk of breaking a bone (fracture). These are
New blood test diagnoses heart attacks faster
A new test to assess a whether or not someone is having a heart attack upon arriving in the emergency room was safe and effective,
Women doctors best for women with heart attacks
If you’re having a heart attack and you’re a woman, hope a female doctor greets you in the emergency room. A review of nearly 582,000
Traffic noise may raise heart attack risk
Your risk of heart attack increases with the amount of traffic noise to which you are exposed. The increase in risk – though slight –
Mediterranean diet linked to lower risk of heart attacks & strokes
A Mediterranean diet, high in fruit, vegetables, fish and unrefined foods, is linked to a lower risk of heart attack and stroke in people who
ReShape balloon device to treat obesity approved in US
The ReShape Integrated Dual Balloon System (ReShape Dual Balloon) – A new balloon device to treat obesity without the need for invasive surgery is approved
Praluent – alirocumab injection approved for cholesterol-lowering treatment by US FDA
Sanofi and Regeneron Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) approved Praluent® (alirocumab) Injection, the first FDA-approved treatment in a new
New antiplatelet drug Kengreal approved by US FDA
FDA approves new antiplatelet drug used during heart procedure – The U.S. Food and Drug Administration approved Kengreal (cangrelor), an intravenous antiplatelet drug that prevents formation of harmful blood clots in the coronary arteries, the blood vessels that supply blood to the heart.
New cholesterol drug alirocumab halved number of heart attacks and strokes
New drug alirocumab halved number of heart attacks and strokes – An experimental cholesterol-lowering drug from Sanofi and Regeneron Pharmaceuticals roughly halved the number of heart attacks and strokes in a clinical trial, revealed by researchers at the European Society of Cardiology yearly gathering in Barcelona.